- Home
- EVMN vs ISD Comparison
EVMN vs ISD Comparison
Compare EVMN & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | ISD |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.6M | 486.1M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | EVMN | ISD |
|---|---|---|
| Price | $28.46 | $14.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $44.17 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 127.1K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,000,000.00 | N/A |
| Revenue This Year | $89.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 160.00 | N/A |
| 52 Week Low | $13.89 | $10.98 |
| 52 Week High | $33.20 | $13.17 |
Technical Indicators
Market Signals| Indicator | EVMN | ISD |
|---|---|---|
| Relative Strength Index (RSI) | 69.55 | 61.81 |
| Support Level | $15.97 | $14.51 |
| Resistance Level | $33.20 | $14.72 |
| Average True Range (ATR) | 3.05 | 0.12 |
| MACD | 0.89 | 0.01 |
| Stochastic Oscillator | 74.38 | 93.15 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.